(Q31041170)

28 June 2017

1 reference

title

Progress and challenges in screening for early detection of ovarian cancer (English)

1 reference

28 June 2017

1 reference

Usha Menon

2

0 references

author name string

Ian J Jacobs

series ordinal

1

1 reference

28 June 2017

5 February 2004

1 reference

Molecular & Cellular Proteomics

28 June 2017

1 reference

28 June 2017

3

1 reference

28 June 2017

355-366

1 reference

28 June 2017

4

1 reference

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

28 June 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Elevation of multiple serum markers in patients with stage I ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Inhibins/activins as diagnostic markers for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Reactivity of a monoclonal antibody with human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Screening for ovarian cancer: a pilot randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Transvaginal sonography as a screening method for the detection of early ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Bilateral oophorectomy in asymptomatic women over 50 years old selected by ovarian cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Transabdominal ultrasound screening for early ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Transvaginal color Doppler and pelvic tumor vascularity: lessons learned and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

A multidisciplinary approach to the early detection of ovarian carcinoma: rationale, protocol design, and early results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

A data review and re-assessment of ovarian cancer serum proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R400006-MCP200

10.1074/MCP.R400006-MCP200

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

14764655